세계의 호흡 케어 기기 시장 : 예측(2025-2030년)

The Global Respiratory Care Devices Market is expected to grow from USD 25.375 billion in 2025 to USD 35.650 billion in 2030, at a CAGR of 7.04%.

Rising Geriatric Population

The global aging population is a major catalyst for market expansion. The elderly are more susceptible to chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), which significantly boosts demand for respiratory care devices. Japan, with the world's highest proportion of elderly individuals, and other regions like Italy, are seeing increased healthcare needs for age-related conditions. This demographic shift places pressure on health systems to adopt advanced respiratory care technologies, propelling market growth over the forecast period (2023-2028). The rising prevalence of non-communicable diseases among older populations further amplifies the need for innovative devices to manage chronic respiratory conditions effectively.

Increasing Prevalence of COPD

COPD remains a critical driver of market demand, with no cure but treatable through advanced respiratory care devices. Smoking, both active and passive, is a leading cause of COPD, alongside other risk factors like indoor and outdoor pollution and occupational exposures to dust and chemicals. The disease's high prevalence, particularly in low- and middle-income countries, fuels the need for ventilators and other respiratory support devices. The aging global population exacerbates this trend, as COPD is more common among older individuals, further accelerating market growth.

Surge in Preterm Births

The rising incidence of preterm births is another significant factor driving demand for neonatal respiratory care devices. Premature infants, particularly those born before 32 weeks, often suffer from respiratory disorders due to insufficient surfactant production, leading to conditions like apnea of prematurity, bronchopulmonary dysplasia, and pneumonia. According to WHO, approximately 15 million preterm births occur annually, with over 60% in African and South Asian regions. Low- and middle-income countries report higher preterm birth rates (12%) compared to high-income countries (9%). The need to reduce neonatal mortality from respiratory complications has spurred demand for advanced respiratory care devices, creating substantial market opportunities.

Market Segment Analysis

Technological Advancements

Innovations in intelligent ventilation solutions are transforming the respiratory care devices market. Advanced systems can automatically adjust ventilation and oxygenation based on physician-specified goals and patient physiological inputs. These technologies enhance ease of use and improve patient outcomes, driving significant revenue growth. The development of such sophisticated devices presents a robust opportunity for market expansion, particularly for patients with acute or chronic respiratory conditions.

Regional Insights

North America holds a dominant market share due to the high prevalence of chronic respiratory diseases like COPD and substantial healthcare expenditure. Meanwhile, the Asia-Pacific region is the fastest-growing market, driven by a high burden of chronic diseases requiring respiratory support and a significant elderly population, particularly in Japan. These regional dynamics highlight varied growth opportunities across global markets.

Market Challenges

Stringent Regulatory Environment

The market faces challenges due to rigorous regulatory requirements for medical device approvals. Respiratory care devices, classified as Class II devices by the FDA, require premarket notification (510(k)) clearance. These regulations ensure safety but can delay product launches and increase development costs, posing a barrier to market growth. Stringent checkpoints during conception, manufacturing, packaging, and advertising aim to prevent misleading claims but may lead to product disqualifications, impacting market dynamics.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Function

• Diagnosis
• Treatment
• Monitoring

By Device Type

• Ventilator
• Spirometer
• Pulse Oximeter
• Inhaler
• Nebulizer
• Others

By Indication

• COPD
• Asthma
• Sleep Apnea
• Infectious Disease
• Others

By End User

• Hospitals
• Ambulatory Care Center
• Home Healthcare Setting

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Others
• Middle East and Africa
• UAE
• Israel
• Saudi Arabia
• Others
• Asia Pacific
• Japan
• China
• India
• Australia
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. RESPIRATORY CARE DEVICES MARKET BY FUNCTION

• 5.1. Introduction
• 5.2. Diagnosis
• 5.3. Treatment
• 5.4. Monitoring

6. RESPIRATORY CARE DEVICES MARKET BY DEVICE TYPE

• 6.1. Introduction
• 6.2. Ventilator
• 6.3. Spirometer
• 6.4. Pulse Oximeter
• 6.5. Inhaler
• 6.6. Nebulizer
• 6.7. Others

7. RESPIRATORY CARE DEVICES MARKET BY INDICATION

• 7.1. Introduction
• 7.2. COPD
• 7.3. Asthma
• 7.4. Sleep Apnea
• 7.5. Infectious Disease
• 7.6. Others

8. RESPIRATORY CARE DEVICES MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Ambulatory Care Center
• 8.4. Home Healthcare Setting

9. RESPIRATORY CARE DEVICES MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Italy
  • 9.4.6. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. Australia
  • 9.6.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Koninklijke Philips N.V.
• 11.2. Medtronic plc
• 11.3. ResMed Inc.
• 11.4. Fisher & Paykel Healthcare Limited
• 11.5. Dragerwerk AG & Co. KGaA
• 11.6. Masimo Corporation
• 11.7. Becton, Dickinson and Company

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations